Nottingham, MD, United States of America

Jesse Alt

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jesse Alt

Introduction

Jesse Alt is an accomplished inventor based in Nottingham, MD (US). He has made significant contributions to the field of medical science, particularly in the development of treatments for various diseases. His innovative work focuses on glutamine antagonists and their therapeutic applications.

Latest Patents

Jesse Alt holds a patent for "Glutamine antagonists and uses thereof." This patent discloses glutamine antagonists and their use for treating oncological, immunological, and neurological diseases. The patent outlines methods for treating these diseases by administering a therapeutically effective amount of a glutamine antagonist or its pharmaceutical composition. Additionally, it describes methods for enhancing the effects of immune checkpoint inhibitors, enabling subjects to respond better to these treatments. The patent also addresses methods for treating diseases that are refractory to checkpoint inhibitor therapy.

Career Highlights

Throughout his career, Jesse Alt has worked with prestigious institutions, including The Johns Hopkins University and the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences. His work has been instrumental in advancing the understanding and treatment of complex diseases.

Collaborations

Jesse has collaborated with notable professionals in his field, including Barbara S. Slusher and Rana Rais. These collaborations have contributed to the development of innovative solutions in medical research.

Conclusion

Jesse Alt's contributions to the field of medical science through his patent on glutamine antagonists highlight his dedication to improving treatment options for serious diseases. His work continues to inspire advancements in medical research and therapy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…